期刊文献+

大鼠非酒精性脂肪性肝病发展过程中Visfatin水平及其相关因素分析 被引量:1

下载PDF
导出
摘要 目的探讨大鼠非酒精性脂肪性肝病(nonalcoholic fatty liver disease,NAFLD)发生、发展过程中血清Visfatin的水平变化及其与糖脂代谢的相关性。方法以高脂饮食构建NAFLD大鼠模型,应用酶联免疫吸附法、酶法及化学比色法等方法,动态检测大鼠NAFLD发生、发展过程中血清Visfatin、谷丙转氨酶(GPT)、谷草转氨酶(GOT)、甘油三酯(TG)、游离脂肪酸(FFA)、总胆固醇(TC)、高密度脂蛋白(HDL)、低密度脂蛋白(LDL)、空腹血糖(FBG)及空腹胰岛素(FINS)水平,并计算HD饥DL比值及胰岛素抵抗指数(IRI)。结果在模型组大鼠由单纯性脂肪肝(SS)发展为非酒精性脂肪性肝炎(NASH)的过程中,血清Visfatin水平呈由高到低的变化趋势:相关分析显示,血清Visfatin与FFA、LDL及IRI呈正相关,与HDL/LDL比值呈负相关。结论Visfatin的早期高表达考虑与胰岛素抵抗及脂质代谢紊乱相关.可能在NAFLD发展过程中起重要作用。
出处 《中国药业》 CAS 2012年第A02期27-28,共2页 China Pharmaceuticals
基金 国家自然科学基金资助项目,项目编号:81073123 山东省自然科学基金项目资助项目,项目编号Q2008C01.
  • 相关文献

参考文献7

  • 1Olszanecka-Glinianowicz M, Koce?ak P, Nylec M, et al.Circulating vis- fatin level and visfatin/ insulin ratio in obese women with metabolic syndrome [J ].Arch Med Sci ,2012,8(2):214-218.
  • 2McGee KC, Harte AL, da Silva NF, et al.Visfatin is regulated by rosigli- tazone in type 2 diabetes mellitus and influenced by NFKB and JNK in human abdominal subcutaneous adipocytes [J].PLoS One,2011,6(6): e20287.
  • 3Fukuhara A, Matsuda M, Nishizawa M, et al.Visfatin: a protein secreted by visceral fat that mimics the effects of insulin [J].Science ,2005,307 (5708):426-430.
  • 4Dahl TB,Haukeland JW,Yndestad A,et al.Intraeellular nicotinamide phosphoribosyltransfer- ase protects against hepatocyte apoptosis and is down-regulated in nonalcoholic fatty liver disease [J ].J Clin Endocrinol Metab, 2010,95 ( 6 ):3039-3047.
  • 5Akbal E, Ko?ak E,Ta? A, et al.Visfatin levels in nonalcoholic fatty liver disease [ J ] .J Clin Lab Anal, 2012,26 ( 2 ): I 15-119.
  • 6刘圣文,乔树宾,刘东青.内脏脂肪素促进内皮细胞合成单核细胞趋化蛋白1和白介素6的实验研究[J].中华医学杂志,2009,89(40):2843-2846. 被引量:7
  • 7Oita RC, Ferdinando D, Wilson S, et al.Visfatin induces oxidative stress in differentiated C2C12 myotubes in an Akt- and MAPK-independent, NFkB-dependent manner [J].Pfltigers Archiv: European Journal of Physiology ,2010,459(4):619-630.

二级参考文献16

  • 1Braunersreuther V,Mach F,Steffens S.The specific role of chemokines in atheroeclerceis.Thromb Haemost,2007,97:714-721.
  • 2Yudkin JS,Kumari M,Humphries SE,et al.Inflammation,obesity,stress and coronary heart disease:is interleukin-6 the link? Atherosclerosis,2002,148:209-214.
  • 3Samal B,Sun Y,Stearns G,et al.Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor.Mol Cell Biol,1994,14:1431-1437.
  • 4Hammarstedt A,Pihlajamaki J,Rotter Sopasakis V,et al.Visfatin is an adipokine,but it is not regulated by thiazolidinediones.J Clin Endocrinol Metab,2006,91:1181-1184.
  • 5Fukuhara A,Matsuda M,Nishizawa M,et al.Visfatin:a protein secreted by visceral fat that mimics the effects of insulin.Science,2005,307:426-430.
  • 6Moschen AR,Kaser A,Enrich B,et al.Visfatin,an adipocytokine with proinflammatory and immunomodulating properties.J Immunol,2007,178:1748-1758.
  • 7Adya R,Tan BK,Punn A,et al.Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways:novel insights into visfatin-inducecl angingenesis.Cardiovasc Res,2008,78:356-365.
  • 8Kim SR,Bac YH,Bae SK,et al.Visfatin enhances ICAM-1 and VCAM-1 expression through ROS-dependent NF-kappaB activation in endothelial celia.Bioehim Biophys Acta,2008,1783:886-895.
  • 9Ajuwon KM,Spurlock ME.Adiponeetin inhibits LPS-induced NFkappaB activation and IL-6 production and increases PPARgamma2 expression in adipoeytes.Am J Physiol Regul lntegr Comp Physiol,2005,288:R1220-1225.
  • 10Verma S,Li SH,Wang CH,et al.Resist.in promotes endothelial cell activation:further evidence of adipokine-endothelial interaction.Circulation,2003,108:736-740.

共引文献6

同被引文献7

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部